Inhibition of murine γδ lymphocyte expansion and effector function by regulatory αβ T cells is cell-contactdependent and sensitive to GITR modulation

European Journal of Immunology

Volumn 40, Issue 1, 2010, Pages 61-70

  Gonçalves Sousa, Natacha ^a,b   Ribot, Julie C ^a,b   DeBarros, Ana ^a,b   Correia, Daniel V ^a,b   Caramalho, Íris ^a,b   Silva Santos, Bruno ^a,b  

^a UNIVERSITY OF LISBON   (Portugal)

^b INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

Author keywords

T cells; IFN ; IL 17; T cell suppression; Treg

Indexed keywords

GAMMA INTERFERON; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN 17; MONOCLONAL ANTIBODY; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; LYMPHOCYTE ANTIGEN RECEPTOR; NERVE GROWTH FACTOR RECEPTOR; TNFRSF18 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL CONTACT; CELL EXPANSION; CELL FUNCTION; CLONAL ANERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; GAMMA DELTA T LYMPHOCYTE; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MALARIA; MODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY ALPHA BETA T LYMPHOCYTE; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; ANIMAL; BIOSYNTHESIS; CELL COMMUNICATION; CELL PROLIFERATION; COCULTURE; CYTOLOGY; IMMUNOLOGY; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE;

ANIMALS; CELL COMMUNICATION; CELL PROLIFERATION; COCULTURE TECHNIQUES; CYTOKINES; MICE; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 74249122510     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939715     Document Type: Article

References (58)

1. Chen, Z. W., Immune regulation of γδ T cell responses in mycobacterial infections. Clin. Immunol. 2005. 116: 202-207.
2. Kabelitz, D., Wesch, D. and He, W., Perspectives of γδ T cells in tumor immunology. Cancer Res. 2007. 67: 5-8.
3. Jameson, J. and Havran,W. L., Skin γδ T-cell functions in homeostasis and wound healing. Immunol. Rev. 2007. 215: 114-122.
4. Hayday, A. and Tigelaar, R., Immunoregulation in the tissues by γδ T cells. Nat. Rev. Immunol. 2003. 3: 233-242.
5. Beetz, S., Wesch, D., Marischen, L., Welte, S., Oberg, H. H. and Kabelitz, D., Innate immune functions of human γδ T cells. Immunobiology 2008. 213: 173-182.
6. Dieli, F., Troye-Blomberg, M., Farouk, S. E., Sireci, G. and Salerno, A., Biology of γδ T cells in tuberculosis and malaria. Curr. Mol. Med. 2001. 1: 437-446.
7. Ribot, J. C., deBarros, A., Pang, D. J., Neves, J. F., Peperzak, V., Roberts, S. J., Girardi, M. et al., CD27 is a thymic determinant of the balance between interferon-γ- and interleukin-17-producing γδ T cell subsets. Nat. Immunol. 2009. 10: 427-436.
8. Gao, Y., Yang,W., Pan, M., Scully, E., Girardi, M., Augenlicht, L. H., Craft, J. and Yin, Z., γδ T cells provide an early source of interferon-γ in tumor immunity. J. Exp. Med. 2003. 198: 433-442.
9. O'Brien, R. L., Roark, C. L. and Born,W. K., IL-17-producing γδ T cells. Eur. J. Immunol. 2009. 39: 662-666.
10. Jensen, K. D., Su, X., Shin, S., Li, L., Youssef, S., Yamasaki, S., Steinman, L. et al., Thymic selection determines γδ T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon-γ. Immunity 2008. 29: 90-100.
11. Li, L. and Wu, C. Y., CD4+ CD25+ Treg cells inhibit human memory γδ T cells to produce IFN-γin response to M. tuberculosis antigen ESAT-6. Blood 2008. 111: 5629-5636.
12. Martinet, L., Fleury-Cappellesso, S., Gadelorge, M., Dietrich, G., Bourin, P., Fournie, J. J. and Poupot, R., A regulatory cross-talk between Vγ9Vd2 T lymphocytes and mesenchymal stem cells. Eur. J. Immunol. 2009. 39: 752-762.
13. Tang, Q. and Bluestone, J. A., The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 2008. 9: 239-244.
14. Ghiringhelli, F., Menard, C., Terme, M., Flament, C., Taieb, J., Chaput, N., Puig, P. E. et al., CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J. Exp. Med. 2005. 202: 1075-1085.
15. Azuma, T., Takahashi, T., Kunisato, A., Kitamura, T. and Hirai, H., Human CD4+ CD25+ regulatory T cells suppress NKT cell functions. Cancer Res. 2003. 63: 4516-4520.
16. Lim, H. W., Hillsamer, P., Banham, A. H. and Kim, C. H., Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells. J. Immunol. 2005. 175: 4180-4183.
17. Misra, N., Bayry, J., Lacroix-Desmazes, S., Kazatchkine, M. D. and Kaveri, S. V., Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells. J. Immunol. 2004. 172: 4676-4680.
18. Taams, L. S., van Amelsfort, J. M., Tiemessen, M. M., Jacobs, K. M., de Jong, E. C., Akbar, A. N., Bijlsma, J. W. and Lafeber, F. P., Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells. Hum. Immunol. 2005. 66: 222-230.
19. Fontenot, J. D., Gavin, M. A. and Rudensky, A. Y., Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003. 4: 330-336.
20. Hori, S., Nomura, T. and Sakaguchi, S., Control of regulatory T cell development by the transcription factor Foxp3. Science 2003. 299: 1057-1061.
21. Sakaguchi, S., Yamaguchi, T., Nomura, T. and Ono, M., Regulatory T cells and immune tolerance. Cell 2008. 133: 775-787.
22. Mills, K. H., Regulatory T cells: friend or foe in immunity to infection? Nat. Rev. Immunol. 2004. 4: 841-855.
23. Zou, W., Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 2006. 6: 295-307.
24. Kunzmann, V., Kimmel, B., Herrmann, T., Einsele, H. and Wilhelm, M., Inhibition of phosphoantigen-mediated γδ T-cell proliferation by CD4+ CD25+ FoxP3+ regulatory T cells. Immunology 2009. 126: 256-267.
25. Roark, C. L., Simonian, P. L., Fontenot, A. P., Born, W. K. and O'Brien, R. L., γδ T cells: an important source of IL-17. Curr. Opin. Immunol. 2008. 20: 353-357.
26. Pennington, D. J., Silva-Santos, B., Silberzahn, T., Escorcio-Correia, M., Woodward, M. J., Roberts, S. J., Smith, A. L. et al., Early events in the thymus affect the balance of effector and regulatory T cells. Nature 2006. 444: 1073-1077.
27. Apostolou, I. and von Boehmer, H., In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 2004. 199: 1401-1408.
28. Chen, W., Jin, W., Hardegen, N., Lei, K. J., Li, L., Marinos, N., McGrady, G. and Wahl, S. M., Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 2003. 198: 1875-1886.
29. Mahan, C. S., Thomas, J. J., Boom, W. H. and Rojas, R. E., CD4(+) CD25(high) Foxp3(3+) regulatory T cells downregulate human Vδ2(+) T-lymphocyte function triggered by anti-CD3 or phosphoantigen. Immunology 2009. 127: 398-407.
30. Pamplona, A., Ferreira, A., Balla, J., Jeney, V., Balla, G., Epiphanio, S., Chora, A. et al., Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat. Med. 2007. 13: 703-710.
31. Zelenay, S., Lopes-Carvalho, T., Caramalho, I., Moraes-Fontes, M. F., Rebelo, M. and Demengeot, J., Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion. Proc. Natl. Acad. Sci. USA 2005. 102: 4091-4096.
32. French, J. D., Roark, C. L., Born, W. K. and O'Brien R, L., γδ T cell homeostasis is established in competition with T cells and NK cells. Proc. Natl. Acad. Sci. USA 2005. 102: 14741-14746.
33. Grossman, W. J., Verbsky, J. W., Barchet, W., Colonna, M., Atkinson, J. P. and Ley, T. J., Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 2004. 21: 589-601.
34. Gondek, D. C., Lu, L. F., Quezada, S. A., Sakaguchi, S. and Noelle, R. J., Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol. 2005. 174: 1783-1786.
35. Apostolou, I., Sarukhan, A., Klein, L. and von Boehmer, H., Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 2002. 3: 756-763.
36. Haks, M. C., Lefebvre, J. M., Lauritsen, J. P., Carleton, M., Rhodes, M., Miyazaki, T., Kappes, D. J. and Wiest, D. L., Attenuation of γδ TCR signaling efficiently diverts thymocytes to the alphabeta lineage. Immunity 2005. 22: 595-606.
37. Hayes, S. M., Li, L. and Love, P. E., TCR signal strength influences lineage fate. Immunity 2005. 22: 583-593.
38. Jordan, M. S., Boesteanu, A., Reed, A. J., Petrone, A. L., Holenbeck, A. E., Lerman, M. A., Naji, A. and Caton, A. J., Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2001. 2: 301-306.
39. Pennington, D. J., Silva-Santos, B. and Hayday, A. C., γδ T cell development - having the strength to get there. Curr. Opin. Immunol. 2005. 17: 108-115.
40. Romagnoli, P., Hudrisier, D. and van Meerwijk, J. P., Preferential recognition of self antigens despite normal thymic deletion of CD4(+ )CD25(+) regulatory T cells. J. Immunol. 2002. 168: 1644-1648.
41. Hara, M., Kingsley, C. I., Niimi, M., Read, S., Turvey, S. E., Bushell, A. R., Morris, P. J. et al., IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 2001. 166: 3789-3796.
42. Li, M. O., Wan, Y. Y. and Flavell, R. A., T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 2007. 26: 579-591.
43. Collison, L. W., Workman, C. J., Kuo, T. T., Boyd, K., Wang, Y., Vignali, K. M., Cross, R. et al., The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007. 450: 566-569.
44. 3+ regulatory T cell function. Science 2008. 322: 271-275.
45. Read, S., Greenwald, R., Izcue, A., Robinson, N., Mandelbrot, D., Francisco, L., Sharpe, A. H. and Powrie, F., Blockade of CTLA-4 on CD4+ CD25+ regulatory T cells abrogates their function in vivo. J. Immunol. 2006. 177: 4376-4383.
46. Ji, H. B., Liao, G., Faubion,W. A., Abadia-Molina, A. C., Cozzo, C., Laroux, F. S., Caton, A. and Terhorst, C., Cutting edge: the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression. J. Immunol. 2004. 172: 5823-5827.
47. McHugh, R. S., Whitters, M. J., Piccirillo, C. A., Young, D. A., Shevach, E. M., Collins, M. and Byrne, M. C., CD4(+)CD25(+) immuno-regulatoryT cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002. 16: 311-323.
48. Shimizu, J., Yamazaki, S., Takahashi, T., Ishida, Y. and Sakaguchi, S., Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 2002. 3: 135-142.
49. Nocentini, G. and Riccardi, C., GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily. Eur. J. Immunol. 2005. 35: 1016-1022.
50. Tone, M., Tone, Y., Adams, E., Yates, S. F., Frewin, M. R., Cobbold, S. P. and Waldmann, H., Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells. Proc. Natl. Acad. Sci. USA 2003. 100: 15059-15064.
51. Kanamaru, F., Youngnak, P., Hashiguchi, M., Nishioka, T., Takahashi, T., Sakaguchi, S., Ishikawa, I. and Azuma, M., Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells. J. Immunol. 2004. 172: 7306-7314.
52. van Olffen, R.W., Koning, N., van Gisbergen, K. P.,Wensveen, F. M., Hoek, R. M., Boon, L., Hamann, J. et al., GITR triggering induces expansion of both effector and regulatory CD4+ T cells in vivo. J. Immunol. 2009. 182: 7490-7500.
53. Morita, C. T., Jin, C., Sarikonda, G. and Wang, H., Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vγ2Vδ2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol. Rev. 2007. 215: 59-76.
54. Bonneville, M. and Scotet, E., Human Vγ9Vδ2 T cells: promising new leads for immunotherapy of infections and tumors. Curr. Opin. Immunol. 2006. 18: 539-546.
55. Devilder, M. C., Maillet, S., Bouyge-Moreau, I., Donnadieu, E., Bonneville, M. and Scotet, E., Potentiation of antigen-stimulated Vγ9Vδ2 T cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturation. J. Immunol. 2006. 176: 1386-1393.
56. Brandes, M.,Willimann, K. and Moser, B., Professional antigen-presentation function by human γδ T Cells. Science 2005. 309: 264-268.
57. Correia, D. V., d'Orey, F., Cardoso, B. A., Lanca, T., Grosso, A. R., deBarros, A., Martins, L. R. et al., Highly active microbial phosphoantigen induces rapid yet sustained MEK/Erk- and PI-3K/Akt-mediated signal transduction in anti-tumor human γδ T-cells. PLoS One 2009. 4: e5657.
58. Ali, Z., Shao, L., Halliday, L., Reichenberg, A., Hintz, M., Jomaa, H., Chen, Z. W., Prolonged (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate-driven antimicrobial and cytotoxic responses of pulmonary and systemic Vγ2Vδ2 T cells in macaques. J. Immunol. 2007. 179: 8287-8296.